Federal University of Minas Gerais

Appian appoints Silvio Lima as Head of Corporate Affairs, ESG and Community Engagement

Retrieved on: 
Monday, November 21, 2022

Based in London and Brazil, Silvio will be brought into Appian's projects to provide the business' Investment Committee with insights from an ESG and in particular community engagement perspective.

Key Points: 
  • Based in London and Brazil, Silvio will be brought into Appian's projects to provide the business' Investment Committee with insights from an ESG and in particular community engagement perspective.
  • Post-investment, Silvio will be heavily involved in developing and implementing a permitting and community strategy for the Company's local management teams.
  • Michael W. Scherb, Founder and CEO of Appian, commented:"It is great to welcome Silvio, after seeing first-hand his excellent work at Appian Capital Brazil.
  • Silvio Lima, Head of Corporate Affairs, ESG and Community Engagement at Appian, said: "I am delighted to join Appian, after seeing the fantastic work of the business at Appian Capital Brazil since 2019.

Appian appoints Silvio Lima as Head of Corporate Affairs, ESG and Community Engagement

Retrieved on: 
Monday, November 21, 2022

Based in London and Brazil, Silvio will be brought into Appian's projects to provide the business' Investment Committee with insights from an ESG and in particular community engagement perspective.

Key Points: 
  • Based in London and Brazil, Silvio will be brought into Appian's projects to provide the business' Investment Committee with insights from an ESG and in particular community engagement perspective.
  • Post-investment, Silvio will be heavily involved in developing and implementing a permitting and community strategy for the Company's local management teams.
  • Michael W. Scherb, Founder and CEO of Appian, commented:"It is great to welcome Silvio, after seeing first-hand his excellent work at Appian Capital Brazil.
  • Silvio Lima, Head of Corporate Affairs, ESG and Community Engagement at Appian, said: "I am delighted to join Appian, after seeing the fantastic work of the business at Appian Capital Brazil since 2019.

Green Plus® Energy Transition Fuel Generates Fuel Savings and Reduces Harmful Emissions for Brazil

Retrieved on: 
Tuesday, August 16, 2022

PASADENA, Calif., Aug. 16, 2022 /PRNewswire/ -- Biofriendly, a green solutions company, continues to see tremendous growth and expansion of their energy transition fuel, Green Plus, in the Brazilian fuel sector. Brought to the Brazilian market by Horeb Brazil, whose headquarters are in Rio de Janeiro, Green Plus proves to be the environmental fuel solution needed for both businesses and consumers. Represented by Horeb Energy CEO Pedro Ceja Velasco, the company will present at the 15th Annual São Paulo Expo, known as ExpoPostos and Conveniência 2022.

Key Points: 
  • Following successful tests in Belo Horizonte and Joo Pessoa, Biofriendly and Horeb Energy will increase distribution of Green Plus in the Brazilian market
    PASADENA, Calif., Aug. 16, 2022 /PRNewswire/ -- Biofriendly, a green solutions company, continues to see tremendous growth and expansion of their energy transition fuel, Green Plus, in the Brazilian fuel sector.
  • Brought to the Brazilian market by Horeb Brazil, whose headquarters are in Rio de Janeiro, Green Plus proves to be the environmental fuel solution needed for both businesses and consumers.
  • "As a company, Horeb Energy is committed to making the world a better place by improving the energy efficiency of our fuel while reducing harmful emissions," said Pedro Ceja Velasco.
  • "Our ongoing partnership with Biofriendly has allowed Green Plus to fulfill the needs of the people who demand an energy transition fuel today."

Knight Therapeutics Assumes Commercial Activities and Re-Launches Exelon in Brazil

Retrieved on: 
Monday, August 15, 2022

MONTREAL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has assumed full commercial activities and is re-launching Exelon (rivastigmine) in Brazil following successful transfer of the marketing authorization.

Key Points: 
  • MONTREAL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has assumed full commercial activities and is re-launching Exelon (rivastigmine) in Brazil following successful transfer of the marketing authorization.
  • Exelon is a prescription product that was first approved in 1997 and is currently registered and sold in approximately 90 countries.
  • Exelon is indicated for the symptomatic treatment of mild to moderately severe dementia in people with Alzheimer's disease and Parkinson's disease.
  • For more information about Knight Therapeutics Inc., please visit the company's web site at www.gud-knight.com or www.sedar.com .

Fintech Unicorn Neon Appoints Bay Area Tech Veteran to Role of Chief Design Officer

Retrieved on: 
Monday, April 11, 2022

Neon, which recently achieved unicorn status with its latest round of funding, believes that everyone deserves a bright future. The company was founded with the specific mission to decrease inequality and promote change -- in the lives of its customers and in the country of Brazil.

Key Points: 
  • Pereira, who previously held the position of senior product design manager at Twitter will now lead Neons fintech product design.
  • Neon, which recently achieved unicorn status with its latest round of funding, believes that everyone deserves a bright future.
  • My main focus at Neon will be to use my inclusive design experience to ensure we build accessible products that work for everyone.
  • This initiative will make it easy for the new Chief Design Officer to lead his department from the San Francisco Bay Area in the United States, where he currently resides.

Afya Limited Announces Vice President of Innovation & Digital Services Transition Plan

Retrieved on: 
Wednesday, January 19, 2022

Afya Limited, or Afya (Nasdaq: AFYA), today announced that Jlio de Angeli, its Vice President of Innovation & Digital Services, notified the company of his intention to leave for personal reasons.

Key Points: 
  • Afya Limited, or Afya (Nasdaq: AFYA), today announced that Jlio de Angeli, its Vice President of Innovation & Digital Services, notified the company of his intention to leave for personal reasons.
  • Mr. de Angeli will remain in the company to ensure an effective transition of his duties until the end of January 2022.
  • We are grateful for the time Mr. de Angeli has spent with us developing our digital services strategy and we wish him all the best, said Virgilio Gibbon, CEO of Afya.
  • Afya also announced that Lelio de Souza, who has joined Afya effective as of November 2021, will assume the position of Vice President of Digital Services Officer effective as of today.

Victory Square Provides Corporate Update on Record Year

Retrieved on: 
Wednesday, December 30, 2020

Through a blend of video game development, theme park engineering and the latest VR/AR/MR technologies, the company has amassed a portfolio of global brands.

Key Points: 
  • Through a blend of video game development, theme park engineering and the latest VR/AR/MR technologies, the company has amassed a portfolio of global brands.
  • Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais.
  • Victory Square Health took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansens Disease, Brucellosis, HTLV and Blood samples screening tests.
  • Victory Square Technologies Inc. has entered into an engagement with Edge Investments Ltd. of Vancouver, B.C., Canada, to provide investor relations and capital markets advisory services to the company.